GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $308,000 | 0.0% | 7,082 | 0.0% | 0.04% | +16.1% |
| Q1 2022 | $308,000 | -12.7% | 7,082 | -11.6% | 0.03% | -6.1% |
| Q4 2021 | $353,000 | +15.7% | 8,007 | +0.2% | 0.03% | +13.8% |
| Q3 2021 | $305,000 | -4.1% | 7,995 | +0.2% | 0.03% | -3.3% |
| Q2 2021 | $318,000 | +12.0% | 7,983 | +0.2% | 0.03% | +3.4% |
| Q1 2021 | $284,000 | -3.1% | 7,968 | +0.1% | 0.03% | -9.4% |
| Q4 2020 | $293,000 | 0.0% | 7,957 | 0.0% | 0.03% | -8.6% |
| Q3 2020 | $293,000 | -13.1% | 7,957 | -2.8% | 0.04% | -18.6% |
| Q2 2020 | $337,000 | 0.0% | 8,185 | 0.0% | 0.04% | -14.0% |
| Q1 2020 | $337,000 | -11.5% | 8,185 | +0.2% | 0.05% | +11.1% |
| Q4 2019 | $381,000 | +12.7% | 8,165 | +0.1% | 0.04% | +2.3% |
| Q3 2019 | $338,000 | +3.7% | 8,156 | +0.1% | 0.04% | +4.8% |
| Q2 2019 | $326,000 | +6.2% | 8,146 | +11.1% | 0.04% | +5.0% |
| Q1 2019 | $307,000 | -11.0% | 7,335 | -18.7% | 0.04% | -21.6% |
| Q4 2018 | $345,000 | -2.0% | 9,025 | +3.0% | 0.05% | +18.6% |
| Q3 2018 | $352,000 | +16.2% | 8,765 | +16.8% | 0.04% | +10.3% |
| Q2 2018 | $303,000 | -13.7% | 7,506 | -16.5% | 0.04% | -15.2% |
| Q1 2018 | $351,000 | +16.6% | 8,994 | +6.0% | 0.05% | +17.9% |
| Q4 2017 | $301,000 | -0.7% | 8,483 | +13.5% | 0.04% | -7.1% |
| Q3 2017 | $303,000 | -17.0% | 7,474 | -11.7% | 0.04% | -33.3% |
| Q2 2017 | $365,000 | +2.2% | 8,466 | +0.1% | 0.06% | 0.0% |
| Q1 2017 | $357,000 | +11.9% | 8,456 | +2.2% | 0.06% | +3.3% |
| Q4 2016 | $319,000 | +7.8% | 8,276 | +20.7% | 0.06% | +3.4% |
| Q3 2016 | $296,000 | -22.9% | 6,858 | -22.5% | 0.06% | -23.4% |
| Q2 2016 | $384,000 | +38.6% | 8,850 | +29.6% | 0.08% | +32.8% |
| Q1 2016 | $277,000 | -0.7% | 6,831 | -1.3% | 0.06% | -3.3% |
| Q4 2015 | $279,000 | -7.9% | 6,921 | -12.3% | 0.06% | -10.4% |
| Q3 2015 | $303,000 | -7.6% | 7,890 | +0.1% | 0.07% | +1.5% |
| Q2 2015 | $328,000 | -16.5% | 7,881 | -7.5% | 0.07% | -15.4% |
| Q1 2015 | $393,000 | +6.2% | 8,516 | -1.6% | 0.08% | +5.4% |
| Q4 2014 | $370,000 | -7.0% | 8,657 | +0.1% | 0.07% | -8.6% |
| Q3 2014 | $398,000 | -12.9% | 8,649 | +1.3% | 0.08% | -10.0% |
| Q2 2014 | $457,000 | +0.2% | 8,539 | +0.1% | 0.09% | -4.3% |
| Q1 2014 | $456,000 | +0.2% | 8,530 | +0.1% | 0.09% | -3.1% |
| Q4 2013 | $455,000 | +7.3% | 8,523 | +0.8% | 0.10% | 0.0% |
| Q3 2013 | $424,000 | +1.7% | 8,455 | +1.3% | 0.10% | -6.7% |
| Q2 2013 | $417,000 | – | 8,349 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |